New real-world data shows high rates of GLP-1 reinstatement driven by weight regain and return of metabolic health concerns after stopping.
Tag: glp
New Oral GLP-1 Drug for Diabetes Shows Major Blood Sugar and Weight Loss Results
Phase 3 trial results for an oral GLP-1 medication demonstrated significant improvement in type 2 diabetes management, building on injectable drug success.
GLP-1 Drugs May Weaken Link Between Impulsive Behaviour and Violence — Rutgers Study
A Rutgers University study found that Ozempic and Wegovy may reduce how often impulsive tendencies translate into violent actions in at-risk individuals.
Oral GLP-1 Drug for Type 2 Diabetes Shows Major Blood Sugar and Weight Loss in Trial
A new once-daily oral semaglutide variant delivered significant reductions in blood glucose and body weight in a major phase 3 clinical trial.
GLP-1 Drugs Tied to Higher Risk of Dizziness and Fainting in Patients on Multiple BP Meds
A new Medscape-reported study found hypotension-related events increased when GLP-1 drugs were started in patients already on multiple blood pressure medications.
GLP-1 Drugs Opening Door to Future Where Obesity Is Fully Treatable — Experts
A ScienceDaily report highlights expert optimism that GLP-1 medications plus minimally invasive procedures could make effective obesity care universally available.
GLP-1 Drugs Are Changing More Than Just Weight Loss
Ozempic-class drugs are showing surprising benefits beyond obesity — from reducing cancer risk to potentially curbing violent impulses.
New Oral GLP-1 Medication Shows Dramatic Blood Sugar and Weight Loss in Major Clinical Trial
A landmark trial reveals an oral version of GLP-1 medication dramatically improves blood sugar control and drives significant weight loss in type 2 diabetes.
The New GLP-1 Pill Could Be a Diabetes Game-Changer — But Who Will Afford It?
Opinion on the promise and pricing challenges of a new oral GLP-1 medication that dramatically improves blood sugar in clinical trials.
GLP-1 Drugs Found to Reduce Addiction and Overdose Risk in New Large Study
Study of over 600000 US veterans shows GLP-1 drugs may dramatically cut addiction risk broadening their potential medical applications